Marker gets $1.6M NIH grant to further screening technology

03/15/2012 | GenomeWeb Daily News (free registration)

The NIH's National Institute of Neurological Disorders and Stroke awarded Marker Gene Technologies a Phase II small business innovation research grant to help advance its screening technology for lysosomal storage disease drugs. Marker will use the three-year grant worth $1.6 million to develop live cell and tissue tests for drug candidates.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director Quality Improvement
Molina Healthcare of Texas
San Antonio, TX
Senior Medical Director
Network Health
Medford, MA
SVP/Head of Health Plans and Managed Care
Avalere Health
Washington, DC
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR